Matt Stange

Matt Stange currently serves as Vice President of Business Development for Clinical Trials at AdhereTech, a position held since April 2024. Prior to this role, Matt Stange was Global Marketing & Commercial Strategy Leader at Otsuka Pharmaceutical Companies (U.S.) from January 2016 to April 2024, where responsibilities included spearheading the global launch of Sibeprenlimab for rare autoimmune diseases and leading the HCP Marketing for the successful launch of Abilify Asimtufii. Early career experience includes serving as Director of Sales and Marketing at Emware Emergency Systems and as Assistant Manager of Immunology Research & Lab Operations at UC Davis Medical Center. Matt Stange holds an MBA from Auburn University Harbert College of Business and a B.S. in Microbiology and Immunology from the University of California, Davis.